Mesa Laboratories (MLAB) Short term Debt (2011 - 2026)

Mesa Laboratories has disclosed Short term Debt across 12 years of filings, most recently posting $5.6 million for Q2 2026.

• In Q2 2026, Short term Debt fell 94.23% year-over-year to $5.6 million; the TTM figure through Jun 2026 stood at $5.6 million (down 94.23% YoY), while the FY2026 annual figure was $5.6 million, down 94.22% from the prior year.
• Short term Debt came in at $5.6 million for Q2 2026 at Mesa Laboratories, roughly flat from $5.6 million in the prior quarter.
• In the past five years, Short term Debt ranged from a high of $97.4 million in Q2 2025 to a low of $3.8 million in Q2 2024.
• Average Short term Debt over 3 years is $46.0 million, with a median of $5.6 million recorded in 2026.
• The largest YoY upside for Short term Debt was 2498.19% in 2025 against a maximum downside of 95.17% in 2025.
• Over 3 years, Short term Debt stood at $97.3 million in 2024, then plunged by 94.7% to $5.2 million in 2025, then gained by 9.1% to $5.6 million in 2026.
• Per Business Quant data, the three most recent Short term Debt figures were $5.6 million in Q2 2026, $5.6 million in Q1 2026, and $5.2 million in Q4 2025.